183 related articles for article (PubMed ID: 34283223)
1. Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates.
Díez-Aguilar M; Ekkelenkamp M; Morosini MI; Huertas N; Del Campo R; Zamora J; Fluit AC; Tunney MM; Obrecht D; Bernardini F; Cantón R
J Antimicrob Chemother; 2021 Sep; 76(10):2578-2585. PubMed ID: 34283223
[TBL] [Abstract][Full Text] [Related]
2. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
[No Abstract] [Full Text] [Related]
3. Antimicrobial effects of Melaleuca alternifolia (tea tree) essential oil against biofilm-forming multidrug-resistant cystic fibrosis-associated Pseudomonas aeruginosa as a single agent and in combination with commonly nebulized antibiotics.
Haines RR; Putsathit P; Tai AS; Hammer KA
Lett Appl Microbiol; 2022 Sep; 75(3):578-587. PubMed ID: 34687564
[TBL] [Abstract][Full Text] [Related]
4. Optimization of colistin dosing regimen for cystic fibrosis patients with chronic Pseudomonas aeruginosa biofilm lung infections.
Hengzhuang W; Green K; Pressler T; Skov M; Katzenstein TL; Wu X; Høiby N
Pediatr Pulmonol; 2019 May; 54(5):575-580. PubMed ID: 30803159
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.
Ekkelenkamp MB; Cantón R; Díez-Aguilar M; Tunney MM; Gilpin DF; Bernardini F; Dale GE; Elborn JS; Bayjanov JR; Fluit A
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767727
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA
J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
[TBL] [Abstract][Full Text] [Related]
7. Mutations in genes
Ghassani A; Triponney P; Bour M; Plésiat P; Jeannot K;
Antimicrob Agents Chemother; 2024 Jan; 68(1):e0129823. PubMed ID: 38092672
[TBL] [Abstract][Full Text] [Related]
8. Murepavadin activity tested against contemporary (2016-17) clinical isolates of XDR Pseudomonas aeruginosa.
Sader HS; Flamm RK; Dale GE; Rhomberg PR; Castanheira M
J Antimicrob Chemother; 2018 Sep; 73(9):2400-2404. PubMed ID: 29901750
[TBL] [Abstract][Full Text] [Related]
9. Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates.
Díez-Aguilar M; Hernández-García M; Morosini MI; Fluit A; Tunney MM; Huertas N; Del Campo R; Obrecht D; Bernardini F; Ekkelenkamp M; Cantón R
J Antimicrob Chemother; 2021 Mar; 76(4):984-992. PubMed ID: 33367642
[TBL] [Abstract][Full Text] [Related]
10. Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
Jabalameli F; Emaneini M; Beigverdi R; Halimi S; Siroosi M
Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):61. PubMed ID: 37475017
[TBL] [Abstract][Full Text] [Related]
11. Combination of hypothiocyanite and lactoferrin (ALX-109) enhances the ability of tobramycin and aztreonam to eliminate Pseudomonas aeruginosa biofilms growing on cystic fibrosis airway epithelial cells.
Moreau-Marquis S; Coutermarsh B; Stanton BA
J Antimicrob Chemother; 2015 Jan; 70(1):160-6. PubMed ID: 25213272
[TBL] [Abstract][Full Text] [Related]
12. Biofilm-producing potential of urinary pathogens isolated from chronic and recurrent urinary tract infections and impact of biofilm on gentamicin and colistin in vitro efficacy.
Vašková S; Slobodníková L; Fajtl D; Blažíčková S; Botek R; Melicháčová V
Epidemiol Mikrobiol Imunol; 2020; 69(1):3-9. PubMed ID: 32326710
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.
Breen SKJ; Harper M; López-Causapé C; Rogers KE; Tait JR; Smallman TR; Lang Y; Lee WL; Zhou J; Zhang Y; Bulitta JB; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
Int J Antimicrob Agents; 2024 Jun; 63(6):107161. PubMed ID: 38561094
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions.
Pompilio A; Crocetta V; Pomponio S; Fiscarelli E; Di Bonaventura G
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):318-25. PubMed ID: 26004353
[TBL] [Abstract][Full Text] [Related]
15. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides.
Dosler S; Karaaslan E
Peptides; 2014 Dec; 62():32-7. PubMed ID: 25285879
[TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.
Hengzhuang W; Wu H; Ciofu O; Song Z; Høiby N
Antimicrob Agents Chemother; 2012 May; 56(5):2683-90. PubMed ID: 22354300
[TBL] [Abstract][Full Text] [Related]
17. Activity of Antibiotics against Pseudomonas aeruginosa in an
Diaz Iglesias Y; Van Bambeke F
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015047
[No Abstract] [Full Text] [Related]
18. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients.
Sans-Serramitjana E; Fusté E; Martínez-Garriga B; Merlos A; Pastor M; Pedraz JL; Esquisabel A; Bachiller D; Vinuesa T; Viñas M
J Cyst Fibros; 2016 Sep; 15(5):611-8. PubMed ID: 26708265
[TBL] [Abstract][Full Text] [Related]
19. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
20. Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.
Rojo-Molinero E; Macià MD; Rubio R; Moyà B; Cabot G; López-Causapé C; Pérez JL; Cantón R; Oliver A
Antimicrob Agents Chemother; 2016 May; 60(5):2912-22. PubMed ID: 26926631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
